|
|
|
Volumn 5, Issue 2, 2003, Pages 186-191
|
|
Technology evaluation: Reticulose, advanced viral research
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
IMMUNOMODULATING AGENT;
LAMIVUDINE;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RETICULOSE;
SAQUINAVIR;
UNCLASSIFIED DRUG;
ZIDOVUDINE;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADJUVANT ARTHRITIS;
ANTIVIRAL ACTIVITY;
CACHEXIA;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG METABOLISM;
DRUG SYNTHESIS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOMODULATION;
LYMPHOMA;
REVIEW;
SIDE EFFECT;
SOLID TUMOR;
VIRUS INFECTION;
VIRUS LOAD;
VIRUS REPLICATION;
WART VIRUS;
WEIGHT GAIN;
ANTIVIRAL AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
CLINICAL TRIALS, PHASE I;
CLINICAL TRIALS, PHASE II;
HUMANS;
PEPTIDE NUCLEIC ACIDS;
ADENOVIRIDAE;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN PAPILLOMAVIRUS;
HUMAN PAPILLOMAVIRUS TYPES;
PAPILLOMAVIRUS;
|
|
EID: 0038814086
PISSN: 14648431
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (1)
|
|
References (0)
|
